ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ADXS Ayala Pharmaceuticals Inc (QX)

0.64
-0.06 (-8.57%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Ayala Pharmaceuticals (QX) Financial Summary

The current ADXS market cap is 3.1M. The company's latest EPS is USD 0.0000 and P/E is N/A.

Year End December 30 2022 20192020202120222022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 20.88M253k3.24M250k0
Operating Income -17.97M-26.45M-18.79M-19.31M0
Net Income -16.61M-26.47M-17.86M-15.38M0
Year End December 30 2022 20192020202120222022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 45.26M38.53M46.78M25.93M7.77M
Total Liabilities 5.73M8.35M7.89M2.3M8.87M
Total Equity 39.53M30.18M38.89M23.63M-1.1M

Cash Flow

Year End December 30 2022 20192020202120222022
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -36.13M-21.94M-15.44M-15.28M N/A
Investing -1.2M-748k-11k-166k N/A
Financing 24.57M15.5M31.89M-956k N/A
Market Cap 3.1M
Price to Earnings Ratio N/A
Price to Sales Ratio 0
Price to Cash Ratio 1.29
Price to Book Ratio -2.82
Dividend Yield -

Share Statistics

Shares Outstanding 4.84M
Average Volume (1 week) 11.95k
Average Volume (1 Month) 11.16k
52 Week Change -50.77%
52 Week High 1.95
52 Week Low 0.5112
Spread (Intraday) 0.18 (25.41%)

Company Info

Company Name Ayala Pharmaceuticals Inc (QX)
Address 1209 orange street
wilmington, delaware 19801
Website https://www.ayalapharma.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock